ALC Alcon Inc.
Healthcare$67.70-0.12%ClosedMarket Cap: $33.00B
As of 2026-05-26
Valuation
P/E (TTM)
38.80
PEG
—
P/B
1.48
P/S
3.12
EV/EBITDA
17.29
DCF Value
$79.34
FCF Yield
5.2%
Div Yield
0.5%
Margins & Returns
Gross Margin
54.9%
Operating Margin
12.3%
Net Margin
7.7%
ROE
3.7%
ROA
2.6%
ROIC
3.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.65B | 56.4% | $410.9M | $185.3M | $— | — |
| Q4 null | $2.72B | 54.2% | $313.0M | $217.0M | $— | — |
| FY null | $10.40B | 55.2% | $1.36B | $980.0M | $— | $0.33 |
| Q3 null | $2.61B | 55.8% | $332.0M | $237.0M | $— | — |
| Q2 null | $2.60B | 53.5% | $247.0M | $176.0M | $— | $0.33 |
| Q1 null | $2.47B | 55.9% | $468.0M | $350.0M | $— | — |
| Q4 null | $2.50B | 55.4% | $395.0M | $284.0M | $— | — |
| FY null | $9.91B | 55.6% | $1.41B | $1.02B | $— | $0.26 |
| Q3 null | $2.45B | 55.9% | $332.0M | $263.0M | $— | — |
| Q2 null | $2.50B | 55.0% | $318.0M | $223.0M | $— | $0.26 |
| Q1 null | $2.46B | 56.2% | $368.0M | $248.0M | $— | — |
| Q4 2023 | $2.35B | 54.8% | $208.0M | $427.0M | $0.87 | — |